Chances in the Tournament
Although there’s some tough competition in the Machine Region and beyond, we strongly believe the final bracket results will crystalize in our team’s favor. DECT promises to be an elegant non-invasive and cost-effective option to accurately diagnose gout—one of the most common conditions we encounter in our rheumatology careers. This potential is especially true in cases in which traditional methods have failed, those that are atypical and those that are refractory to standard treatment.
So what’s there to think about? Bet on DECT in Gout.
Leen Al Saleh, MD, is a first-year rheumatology fellow at MedStar/Georgetown Washington Hospital Center, Washington, D.C.
Ajita Acharya, MD, is a first-year rheumatology fellow at MedStar/Georgetown Washington Hospital Center, Washington, D.C.
Elena Obreja, MD, is a second-year rheumatology fellow at MedStar/Georgetown Washington Hospital Center, Washington, D.C.
Akrithi U. Garren, MD, is a faculty rheumatologist at MedStar/Georgetown Washington Hospital Center, Washington, D.C.
References
- Singh JA, Budzik JF, Becce F, et al. Dual-energy computed tomography vs. ultrasound, alone or combined, for the diagnosis of gout: A prospective study of accuracy. Rheumatology (Oxford). 2021 Oct 2;60(10):4861–4867.
- Bongartz T, Glazebrook KN, Kavros SJ, et al. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2015 Jun;74(6):1072–1077.
Experience All of RheumMadness
During RheumMadness, rheumatology concepts represent teams that compete against each other in a tournament, much like basketball teams do in the NCAA’s March Madness tournament. In a series for The Rheumatologist, readers will get a chance to read the scouting reports. Check out the reports from each region:
Region: Cells
Region: Animal House
Region: Machines
Region: People
• False Positive MRI in Axial SpA
Don’t forget to submit your RheumMadness 2022 bracket by March 25. The winner of each match-up is decided by a seven-member Blue Ribbon Panel of rheumatologists. The panel will vote based on which topic they think is most important to patients, providers and researchers—both now and in the future. The more your picks match those of the panel, the more points you get. The tournament results will be released in four rounds from March 26–April 4. Prizes will be given to participants with the top scores in the following categories: 1) attending/APP, 2) fellow and 3) resident/medical student. The prize is a custom RheumMadness coffee mug and a lifetime of bragging rights.